Custom Antibody Services for Post-translational Modification Specific Antibody Discovery
TypeName: Business Offer
Category:
Offer Date:2019/04/16
Country: United States
Summary: Creative Biolabs has developed High-Affi™ technology, which offers antibody discovery services that specific for post-translational modifications on proteins. In comparison with hybridoma technology, phage display technology offers greater advantages. Hybridoma-based monoclonal antibody technology can only generate a small number of binders against a particular immunogen at a time; whereas phage display technology can present the entire antibody repertoire (e.g. 1010) of an immunized animal, in which almost 10% of the antibodies are immunogen(s)-specific. https://www.creative-biolabs.com/Custom-antibody-services-for-post-translational-modification-specific-antibody-discovery.html
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
